OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
October 26, 2020 07:30pm
Here’s a preview of the featured content to watch for this week on Drug Topics®.
October 26, 2020 07:00pm
October 26, 2020 02:40pm
October 26, 2020 12:48pm
October 23, 2020 05:25pm
October 26, 2020
Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.
Controlling exposure to antibiotics is important for stewardship programs, and even more so in neonatal intensive care units.
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
October 23, 2020
Here's the coronavirus-related news from this week that you should know.
Daily multivitamin and mineral supplements can boost immunity in older adults and may lessen time and severity of illnesses.
The combined landscape of flu and COVID-19 presents challenges to vaccine uptake.
October 22, 2020
Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.
Eli Lilly reported new efficacy and safety data for mirikizumab in moderate-to-severe Crohn disease.
The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.